Bionano Genomics
BNGO
10 hedge funds and large institutions have $5.71M invested in Bionano Genomics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
9% less funds holding
Funds holding: 11 → 10 (-1)
20% less capital invested
Capital invested by funds: $7.14M → $5.71M (-$1.43M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$445K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$34.1K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$21K |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$2.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$713K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$176K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$21K |
| 4 |
Millennium Management
New York
|
-$13.1K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $4.63M | +$445K | +170 | +7% |
|
|
WVP
2
Worth Venture Partners
Fort Lee,
New Jersey
| $382K | +$34.1K | +13 | +10% |
|
|
MIM
3
Monashee Investment Management
Boston,
Massachusetts
| $360K | -$713K | -272 | -66% |
|
|
4
Millennium Management
New York
| $199K | -$13.1K | -5 | -6% |
|
5
Federated Hermes
Pittsburgh,
Pennsylvania
| $73K | – | – | – |
|
6
Victory Capital Management
San Antonio,
Texas
| $35K | – | – | – |
|
|
PAM
7
Panagora Asset Management
Boston,
Massachusetts
| $20K | +$21K | +8 | New |
|
8
BlackRock
New York
| $3K | – | – | – |
|
9
Morgan Stanley
New York
| $2K | – | – | – |
|
|
10
Nordea Investment Management
Stockholm,
Sweden
| $2K | +$2.62K | +1 | New |
|
|
PCM
11
Perkins Capital Management
Wayzata,
Minnesota
| – | -$176K | -56 | Closed |
|
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$21K | -7 | Closed |
|
|
13
Acadian Asset Management
Boston,
Massachusetts
| – | -$2K | -1 | Closed |
|
BNGO Hedge Fund Activity: Q1 2019 in Review
10 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2019, worth a combined $5.71M — down 20% from $7.14M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BNGO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Sio Capital Management, adding an estimated $445K. The largest seller was Monashee Investment Management, cutting an estimated $713K.
- 10 institutional investors held Bionano Genomics (BNGO) as of Q1 2019, down from 11 in Q4 2018.
- Funds reported $5.71M of Bionano Genomics stock for Q1 2019, down 20% quarter-over-quarter.
- 2 funds opened new Bionano Genomics positions in Q1 2019 and 3 closed out, a net change of -1 holder.
- The largest Bionano Genomics buyer in Q1 2019 was Sio Capital Management, an estimated $445K added.
- The largest Bionano Genomics seller in Q1 2019 was Monashee Investment Management, an estimated $713K sold.
Based on aggregated 13F filings for Q1 2019.